Artificial liver support: The pipe dream of today should be the reality of the near future

Medical Hypotheses

Volumn 47, Issue 2, 1996, Pages 145-155

  Fouad, F M ^a   Mamer, O A ^a   Shahidi, F ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CARBON TETRACHLORIDE;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTIFICIAL LIVER; DIALYSIS; DONOR; GRAFT REJECTION; IMPLANTATION; LIVER BLOOD FLOW; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALIA; PRIMATES;

EID: 0029766230     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90454-5     Document Type: Article

References (43)

1. Porte R J, Bontempo F A, Knot E A R, Lewis J H, Kang Y G, Starzl T E. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 1989; 47: 978-984.
2. Brunt E M, Peters M G, Flye M W, Hanto D W. Day-5 protocol liver allograft biopsies document early rejection episodes and are predictive of recurrent rejection. Surgery 1992; 111: 511-517.
3. McDiarmid S V, Busuttil R W, Terasaki P, Vargas J H, Ament M E. OKT3 treatment of steroid- resistant rejection in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr 1992; 14: 86-91.
4. Martinez O M, Krams S M, Sterneck M et al. Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992; 53: 449-456.
5. Hamilton G, Prettenhofer M, Zommer A et al. Intraoperative course and prognostic significance of endotoxin, tumor necrosis factor-α and interleukin-6 in liver transplant recipients. Immunobiology 1991; 182: 425-439.
6. Tzakis A G, Gordon R D, Show B H, Iwatsuki S, Starzl T E. Clinical presentation of hepatic artery thrombosis after liver transplantation in cyclosporin era. Transplantation 1985; 40: 667-671.
7. Chari R S, Collins B H, Magee J C et al. Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med 1994; 331: 234-237.
8. Tchervenkov I. Alive - Thanks in part to a pig. Patient tells of transplant 'miracle'. The Montreal Gazette 1995; Jan 28: pp 1 and 5.
9. Cattral M S, Levy G A. Artificial liver support - Pipe dream or reality. Transplantation 1994; 331: 268-269.
10. Maddrey W C, Van Thiel D H. Liver transplantation: an overview. Hepatology 1988; 8: 948-959.
11. Starzl T E, Iwatsuki S, Van Thiel D H et al. Evolution of liver transplantation. Hepatology 1982; 2: 614-636.
12. Jenkins R L. Liver transplantation in the adult. Transplant Rev 1987; 1: 1-30.
13. Marsh J W Jr, Iwatsuki S, Makowka L et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988; 207: 21-25.
14. Maddrey W C. Hepatic vein thrombosis (Budd-Chiari syndrome): possible association with the use of oral contraceptives. Semin Liver Dis 1987; 7: 32-39.
15. Iwatsuki S, Shaw B W Jr, Starzl T E. Liver transplantation for biliary atresia. World J Surg 1984; 8: 51-56.
16. Todo S, Starzl T E, Tzakis A et al. Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatol 1992; 15: 419-422.
17. Yarze J C, Martin P, Munoz S J. Wilson's disease: current status. Am J Med 1992; 92: 643-654.
18. Fung J, Starzl T. Prophylactic use of OKT3 in liver transplantation. A review. Dig Dis Sci 1991; 36: 1427-1430.
19. Yandza T, Rahier J, De Ville de Goyet J, Salizzoni M, de Hemptinne B, Otte J B. Orthoclone OKT3 in in liver transplantation: experience in 21 patients. Transplant Proc 1987; 19: 3987-3990.
20. Singh N, Dummer J S, Kusne S et al. Infection with cytomegalovirus and other herpesvirus in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 in antibodies. J Infect Dis 1988; 158: 124-131.
21. Pillay D, Charman H, Burroughs A K, Smith M, Rolles K, Griffiths P D. Surveillance for CMV infection in orthotopic liver transplant recipients. Transplantation 1992; 53: 1261-1265.
22. McDiarmid S V, Millis M J, Terasaki P I, Ament M E, Busuttil R W. OKT3 prophylaxis in liver transplantation. Dig Dis Sci 1991; 36: 1418-1426.
23. Tilg H, Nordberg J, Vogel W et al. Circulating serum levels of interleukin 6 and C creative protein after liver transplantation. Transplantation 1992; 54: 142-146.
24. Van Thiel D H, Finkel R, Friedlander L, Gavaler J, Wright H I, Gordon R. The association of IgA deficiency but not IgG or IgM deficiency with a reduced patient and graft survival following liver transplantation. Transplantation 1992; 54: 269-273.
25. O'Grady J G, Smith H M, Davies S E et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 1992; 14: 104-111.
26. Pontisso P, Poon M C, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in mononuclear blood cells. Br Med J 1984; 288: 1563-1566.
27. Davison F, Alexander G J M, Trowbridge R, Fagan E A, Williams R. Detection of hepatitis B virus DNA in spermatozoa, urine, saliva and leucocytes, of chronic NBsAg carriers: a lack of relationship with serum markers of replication. J Hepatol 1987; 4: 37-44.
28. Nowak R. Xenotransplants set to resume. Science 1994; 266: 1148-1151.
29. Geller R L, Turman M A, Dalmasso A P, Platt L. The natural immune barrier to xenotransplantation. J Am Soc Nephrol 1992; 3: 1189-1200.
30. Fouad M F, Marshall W D, Farrell P G, FitzGerald S, Scherer R, Ruhenstroth-Bauer G. Study of hepatotoxicity in isolated perfused liver versus cultures of rat hepatocytes. J Toxicol Environ Health 1989; 26: 83-99.
31. Sganga G, Siegel J H, Brown G et al. Reprioritization of hepatic plasma protein release in trauma and sepsis. Arch Surg 1985; 120: 187-199.
32. Fouad F M, Goldberg M, Ruhenstroth-Bauer G. Plasma protein determination as a clinical probe for liver injury in rats induced by thioacetamide, alloxan or ixoten. J Clin Chem Clin Biochem 1983; 203-208.
33. Fouad F M, Farrell P G, Marshall W, Scherer R, Ruhenstroth-Bauer G. Partially hepatectomized rats: a model for the study of the effect of toxins on the plasma protein profile of nascent hepatocyte. J Toxicol Environ Health 1992; 36: 43-57.
34. Koj A. Acute-phase reactants: their synthesis, turnover and biological significance. In: Allison A C, ed. Structure and Function of Plasma Proteins, Vol 1. New York: Plenum 1974; 21: 73-125.
35. Lalli E, Meliconi R, Conte R et al. Serum markers of immune activation and liver allograft rejection. Dig Dis Sci 1992; 37: 1116-1120.
36. 1-antichymotrypsin in liver diseases and after liver transplantation. Clin Sci 1992; 82: 439-446.
37. Henley K S, Lucey M R, Appelman H D et al. Biochemical and histopathological correlation in liver transplant: the first 180 days. Hepatol 1992; 16: 688-693.
38. Todd N J, Whicher J T, Westacott C, Gilbert A. The acute phase protein response in mice does not show tolerance to recurrent sterile inflammation. Clin Chem Acta 1990; 198: 47-54.
39. Fouad M F, Mamer O A, Shahidi F. Acute-phase response in rat to carbontetrachloride-azathioprine induced cirrhosis and partial hepatectomy of cirrhotic liver. J Toxicol Environ Health 1996; 47: 601-615.
40. Milland J, Tsykin A, Thomas T, Aldred A R, Cole T, Schreiber G. Gene expression in regenerating and acute-phase rat liver. Am J Physiol 1990; 259: G340-G347.
41. Goldberg M, Strecker W, Feeny D, Ruhenstroth-Bauer G. Evidence for and characterization of a liver cell proliferation factor from blood plasma of partially hepatectomized rats. Horm Metab Res 1980; 12: 94-96, and Higgins G M, Anderson R M. Experimental pathology of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186-202.
42. Goldberg M, Strecker W, Feeny D, Ruhenstroth-Bauer G. Evidence for and characterization of a liver cell proliferation factor from blood plasma of partially hepatectomized rats. Horm Metab Res 1980; 12: 94-96, and Higgins G M, Anderson R M. Experimental pathology of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186-202.
43. Fouad F M, Shahidi F, Mamer O A. Heat stressed oxidized-lipid and acetaminophen induced-liver cirrhosis. J Toxicol Environ Health 1995; 46: 217-232.